May 14, 2020 / 10:49 AM / 15 days ago

BRIEF-Avicanna Enters Into A Multi-Faceted Strategic Manufacturing Agreement With Medipharm Labs

May 14 (Reuters) - Avicanna Inc:

* AVICANNA SIGNS WIDE-RANGING STRATEGIC MANUFACTURING AND IP LICENSING AGREEMENT WITH WORLD-CLASS CANADIAN MANUFACTURER MEDIPHARM LABS

* AVICANNA INC - ENTERED INTO A MULTI-FACETED STRATEGIC MANUFACTURING AGREEMENT WITH MEDIPHARM LABS CORP

* AVICANNA INC - PARTNERSHIP PROVIDES AVICANNA WITH A COMMERCIAL PATHWAY TO CANADIAN AND INTERNATIONAL SALES

* AVICANNA INC - PARTNERSHIP PROVIDES CO WITH PHARMACEUTICAL MANUFACTURING OF ITS PRODUCTS DESTINED FOR CLINICAL DEVELOPMENT WITH ITS CANADIAN PARTNERS

* AVICANNA - WILL GRANT MEDIPHARM LABS LICENSE TO USE CO’S PROPRIETARY FORMULATIONS TO DEVELOP ADDITIONAL MEDIPHARM LABS & WHITE LABEL BRANDED PRODUCTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below